Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Medications

CDC proposes softer guidance on opioid prescriptions

The nation's top public health agency on Thursday proposed changing—and in some instances, softening—guidelines for U.S. doctors prescribing oxycodone and other opioid painkillers.

page 14 from 40